As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening (Business Wire)
- AI Tool Identifies Undiagnosed Early-Stage MASLD (MDedge)
- Joining forces to develop a multidisciplinary care model in GI (Takeda)
- Zepbound sheds more weight than Wegovy in trial, Eli Lilly says (NBC News)
- Cheap, non-invasive tool that detects bowel disease coming in 2027: Hong Kong scientists (South China Morning Post)
- Some Older Adults Think Stopping CRC Screening at Age 75 Is ‘Unacceptable’ (MedPage Today)
- Why Operators Are Embracing Hybrid ASC, Office-Based Lab Models (ASC News)
- This year, be thankful for AI in medicine (The Washington Post)